Optimal adaptive randomized designs for clinical trials
临床试验的最优自适应随机设计AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要直接研究治疗随机分配、自适应试验设计与分配偏差,属于因果研究的实验设计方向。
临床试验的最优自适应随机设计AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Optimal decision-analytic designs are deterministic. Such designs are appropriately criticized in the context of clinical trials because they are subject to assignment bias. On the other hand, balanced randomized designs may assign an excessive number of patients to a treatment arm that is performing relatively poorly. We propose a compromise between these two extremes, one that achieves some of the good characteristics of both. We introduce a constrained optimal adaptive design for a fully sequential randomized clinical trial with k arms and n patients. An r-design is one for which, at each allocation, each arm has probability at least r of being chosen, 0 ⩽ r ⩽ 1/k. An optimal design among all r-designs is called r-optimal. An r1-design is also an r2-design if r1 ⩾ r2. A design without constraint is the special case r = 0 and a balanced randomized design is the special case r = 1/k. The optimization criterion is to maximize the expected overall utility in a Bayesian decision-analytic approach, where utility is the sum over the utilities for individual patients over a ‘patient horizon’ N. We prove analytically that there exists an r-optimal design such that each patient is assigned to a particular one of the arms with probability 1 − (k − 1)r, and to the remaining arms with probability r. We also show that the balanced design is asymptotically r-optimal for any given r, 0 ⩽ r < 1/k, as N/n → ∞. This implies that every r-optimal design is asymptotically optimal without constraint. Numerical computations using backward induction for k = 2 arms show that, in general, this asymptotic optimality feature for r-optimal designs can be accomplished with moderate trial size n if the patient horizon N is large relative to n. We also show that, in a trial with an r-optimal design, r < 1/2, fewer patients are assigned to an inferior arm than when following a balanced design, even for r-optimal designs having the same statistical power as a balanced design. We discuss extensions to various clinical trial settings.
内生性检验:一种基于矩的贝叶斯方法
A standard assumption in the Bayesian estimation of linear regression models is that the regressors are exogenous in the sense that they are uncorrelated with the model error term. In practice, however, this assumption can be invalid. In this article, using the exponentially tilted empirical likelihood (ETEL) framework, we develop a Bayes factor test for endogeneity that compares a base model that is correctly specified under exogeneity but misspecified under endogeneity…
自适应实验中策略改进价值的推断
In this paper, we develop an asymptotically normal estimator for the value of policy improvement (VPI) under adaptively collected data. This value, which is defined as the gap between the value of the best treatment policy in a class and that of a baseline policy, gauges whether or not it is worth deploying a personalized treatment policy. Building an estimator for the VPI is naturally more difficult than estimating the value of a fixed policy. This is because, in addition…
潜在类别对处理效应的调节
Many treatments have effects that plausibly vary by latent classes. For example, the effect of personalized video recommendations may be stronger for users who seek a new discovery than for users seeking to rewatch something familiar. In the context of user journeys on digital platforms, we can conceptualize user moods as dynamic latent states that lead to distinct action distributions. Because mood is unobserved, we infer it from a user's pre-treatment actions using a…
存在异质性时利用混合先验自适应结合随机试验与外部对照
When resources are limited in a randomized trial, a common strategy is to augment data from the control arm with external controls. We propose a hybrid group sequential Bayesian design that uses this approach to compare time-to-event distributions. The design allows between-treatment effects to differ between patient subgroups, and adaptively combines subgroups that have similar hazard functions. The aim is to reduce the control arm sample size without compromising the…
重加权分布中选择直接原因的评分方法
Scoring methods based on the Bayesian information criterion (BIC) are commonly used for model selection tasks such as choosing features in a regression model or learning directed acyclic graphs from data. In certain model classes, model selection based on the BIC is consistent. However, since the BIC is based on the observed likelihood function, it does not apply directly to reweighted distributions arising in causal inference, missing data, and domain shift applications.…
贝叶斯神经网络辅助多处理混合治愈生存模型:儿科肿瘤应用
Estimating covariate-conditional treatment effects in multi-arm oncology studies is complicated when treatment arms have common distributional features and a non-negligible fraction of patients achieve long-term remission. We propose a joint mixture cure model with covariate-dependent mixtures of log-normal kernels with treatment-specific inclusions. Both linear and neural-network-assisted non-linear covariate links are proposed. Specifically, the susceptible survival…